Your browser doesn't support javascript.
loading
Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3: European Organization for Research and Treatment of Cancer (EORTC) phase II trial 90101 'CREATE'.
Schöffski, P; Wozniak, A; Kasper, B; Aamdal, S; Leahy, M G; Rutkowski, P; Bauer, S; Gelderblom, H; Italiano, A; Lindner, L H; Hennig, I; Strauss, S; Zakotnik, B; Anthoney, A; Albiges, L; Blay, J-Y; Reichardt, P; Sufliarsky, J; van der Graaf, W T A; Debiec-Rychter, M; Sciot, R; Van Cann, T; Marréaud, S; Raveloarivahy, T; Collette, S; Stacchiotti, S.
Afiliación
  • Schöffski P; Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven, Belgium. Electronic address: patrick.schoffski@uzleuven.be.
  • Wozniak A; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Kasper B; Sarcoma Unit, Interdisciplinary Tumor Center, Mannheim University Medical Center, Mannheim, Germany.
  • Aamdal S; Department of Oncology, Oslo University Hospital, Oslo, Norway.
  • Leahy MG; The Christie NHS Foundation Trust, Manchester, UK.
  • Rutkowski P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland.
  • Bauer S; Department of Internal Medicine, West German Cancer Center, University Hospital, University of Duisburg-Essen, Essen, Germany; German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany.
  • Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
  • Italiano A; Sarcoma Unit, Institut Bergonié, Bordeaux, France.
  • Lindner LH; Medical Clinic III, University Hospital of Munich, Munich, Germany.
  • Hennig I; Department of Clinical Oncology, Nottingham University Hospitals NHS Trust, Nottingham, UK.
  • Strauss S; Department of Oncology, University College Hospital, London, UK.
  • Zakotnik B; Department of Medical Oncology, The Institute of Oncology, Ljubljana, Slovenia.
  • Anthoney A; Institute of Oncology, Leeds Teaching Hospitals National Health Service Trust, St. James's University Hospital, Leeds, UK.
  • Albiges L; Department of Medical Oncology, Gustave Roussy, Villejuif.
  • Blay JY; Department of Medical Oncology, Centre Léon Bérard, Lyon, France; Université Claude Bernard Lyon I, Lyon, France.
  • Reichardt P; Department of Interdisciplinary Oncology, HELIOS Klinikum Berlin-Buch, Berlin, Germany.
  • Sufliarsky J; National Cancer Institute, Bratislava, Slovakia.
  • van der Graaf WTA; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Debiec-Rychter M; Department of Human Genetics, KU Leuven, Leuven, Belgium; University Hospitals Leuven, Leuven, Belgium.
  • Sciot R; University Hospitals Leuven, Leuven, Belgium; Department of Pathology, KU Leuven; Leuven, Belgium.
  • Van Cann T; Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Marréaud S; European Organization for Research and Treatment of Cancer, Brussels, Belgium.
  • Raveloarivahy T; European Organization for Research and Treatment of Cancer, Brussels, Belgium.
  • Collette S; European Organization for Research and Treatment of Cancer, Brussels, Belgium.
  • Stacchiotti S; Department of Medical Oncology, IRCCS Fondazione Istituto Nazionale Tumori, Milano, Italy.
Ann Oncol ; 29(3): 758-765, 2018 03 01.
Article en En | MEDLINE | ID: mdl-29216400
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sarcoma de Parte Blanda Alveolar / Crizotinib / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sarcoma de Parte Blanda Alveolar / Crizotinib / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article